Registro:

Referencias:

• Batlle, A., Porfirias Humanas. Signos y Tratamientos. En Porfirias y Porfirinas. Aspectos clínicos, bioquímicos y biología molecular (1997) Acta Bioquím Clín Latinoam, pp. 37-69
• Maines, M.D., Gibbs, P.E., 30 some years of heme oxygenase: From a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events (2005) Biochem Biophys Res Commun, 338, pp. 568-577
• Sato, H., Higashimoto, Sakamoto, H., Sugishima, M., Takahashi, K., Palmer, G., Electrochemical reduction of ferrous α-verdoheme in complex with heme oxigenase-1 (2007) J Inorg Biochem, 101, pp. 1394-1399
• Tomaro, M.L., Batlle, A.M., Bilirubin: Its role in cytoprotection against oxidative stress. Review (2002) Int J Biochem Cell Biol, 34, pp. 216-220
• Parera, V.E., Fukuda, H., Stella, A.M., Wider, E., Batlle, A.M., Del, C., El saturnismo una porfiria tóxica aguda es una enfermedad toxogenética (1986) Acta Bioquim Clin Latinoam, 20 (3), pp. 345-353
• Polo, C.F., Navone, N.M., Afonso, S.G., Buzaleh, A.M., Shoua, E., Batlle, A., Planificación de los estudios bioquímicos para un Laboratorio de Porfirinas (1988) Acta Bioquím Clin Latinoam, 22, pp. 543-559
• Batlle, A., Stella, A.M., Melito, V.A., Parera, V.E., Diez casos de Porfiria Cutánea Tardía infantil en la Argentina (1989) Acta Bioquím Clin Latinoam, 315, p. 20
• De Siervi, A., Varela, L.S., Méndez, M., Parera, V.E., Batlle Del, A.M.C., Rossetti, M.V., Estudios genéticos de las porfirias agudas en Argentina (2002) Acta Bioquím Clín Latinoam, 36 (5), pp. 505-513
• Martinez Del, M.C., Buzaleh, A.M., Batlle, A., Efecto de la administración de los anestésicos Enflurano e Isoflurano a ratones con niveles inducidos y deprimidos de Citocromo P450. Estudios sobre el sistema enzimático metabolizante de drogas (2005) Acta Bioquím Clin Latinoam, 39, pp. 37-42
• Melito, V.A., Parera, V.E., Rossetti, M.V., Batlle, A., Manifestación de porfiria cutánea tardía en pacientes infectados con el virus de la Inmunodeficiencia humana (2006) Acta Bioquím Clín Latinoam, 40 (1), pp. 29-34
• Rossetti, M.V., Parera, V.E., Melito, V.A., Batlle, A., Porfiria Congénita Eritropoyética en la Argentina: Cuatro niños y un caso de manifestación tardía (2007) Acta Bioquím Clín Latinoam, 41 (3), pp. 359-367
• Batlle, A., Magnin, P., Porfirias y Porfirinas. Aspectos Clínicos y Bioquímicos. Actualizaciones Médico Bioquímicas (1988) Acta Bioquím Clín Latinoam Supl Nro, 2
• Melito, V.A., Rossetti, M.V., Parera, V.E., Batlle, A., Porfirias poco frecuentes. Casos detectados en la población argentian (2006) Rev Argent Dermatol, 87, pp. 248-263
• Cerbino, G.N., Gerez, E.N., Varela, L.S., Melito, V.A., Batlle, A., Parera, V.E., Acute intermittent porphyria in argentine. An Update (2015) BioMed Res Int, p. 946387
• De Siervi, A., Mendez, M., Parera, V.E., Varela, L.S., Batlle, A., Rossetti, M.V., Acute intermittent porphyria: Characterization of two novel mutations in the porphobilinogen deaminase gene, one amino acid deletion (453-455delAGC) and one splicing aceptor site mutation (IVS8-1G®T) (1999) Hum Mutat Mutation in Brief, 14 (4), p. 355
• De Siervi, A., Rossetti, M.V., Parera, V.E., Astrin, K.H., Aizencang, G.I., Glass, I.A., Identification and characterization of Hydroxymethylbilane Synthase mutations causing Acute Intermittent Porphyria: Evidence for an ancestral founder of the common G111R mutation (1999) Am J Med Genet, 86, pp. 366-375
• De Siervi, A., Rossetti, M.V., Parera, V.E., Mendez, M., Varela, L.S., Batlle, A.M., Del, C., Acute intermittent porphyria: Biochemical and clinical analysis in the Argentinean population (1999) Clin Chim Acta, 288, pp. 63-71
• De Siervi, A., Weiss Cádiz, D.E., Parera, V.E., Batlle, A., Rossetti, M.V., Identification and Characterization of two novel mutations that produce Acute Intermittent Porphyria: A 3-base deletion (841-843delGGA) and a missense mutation (T35M) (2000) Hum Mutat Mutation in Brief, 16 (4), p. 373
• Parera, V.E., De Siervi, A., Varela, L.S., Rossetti, M.V., Batlle, A.M., Del, C., Acute porphyrias in the argentinean population: A review (2003) Cell Mol Biol (Noisy-le-grand), 49 (4), pp. 493-500
• Flagel, M.S., Parera, V.E., Batlle, A., Rossetti, M.V., A novel duplication mutation in Argentinean Acute Intermittent Porphyria patients (2011) Gene Bank, p. HQ731552
• Flagel, M.S., Parera, V.E., Batlle, A., Rossetti, M.V., Caracterización de una deleción intrónica en el gen de la PBGD para el diagnóstico presiintomático en Porfiria Aguda Intermitente [resumen] (2012) Medicina, 72, p. 234
• De Siervi, A., Parera, V.E., Batlle, A., Rossetti, M.V., Two new mutations (H106P and L178V) in the protoporphyrinogen oxidase gene in Argentinean patients with Variegate Porphyria (2000) Hum Mutat Mutation and Polymorphism Report, 16 (6), pp. 532-534
• De Siervi, A., Parera, V.E., Varela, L.S., Batlle, A., Rossetti, M.V., A novel mutation (1320InsT) identified in two Argentine families with Variegate Porphyria (2000) Hum Mutat Mutation and Polymorphism Report, 16 (1), p. 96
• De Siervi, A., Parera, V.E., Varela, L.S., Batlle, A., Rossetti, M.V., Porfiria Variegata: signos cutáneos agudos y bioquímicos. Primer estudio genético en pacientes argentinos (2000) Rev Argent Dermatol, 81, pp. 94-100
• Rossetti, M.V., Granata, B.X., Giudice, J., Parera, V.E., Batlle, A., Genetic and biochemical studies in Argentinean patients with Variegate Porphyria (2008) BioMed Central. Medical Genetics, 9, p. 54
• Méndez, M., Granata, B.X., Morán Jiménez, M.J., Parera, V.E., Batlle, A., Enríquez De Salamanca, R., Functional characterization of five protoporphyrinogen oxidase missense. Mutations found in Argentinean Variegate Porphyria patients (2011) JIMD Reports
• Granata, B.X., Baralle, M., De Conti, L., Parera, V.E., Rossetti, M.V., Characterization of Variegate Porphyria mutations using a minigene approach (2014) JIMD Reports
• Granata, B.X., Parera, V.E., Batlle, A., Rossetti, M.V., Haplotype study in Argentinean variegate porphyria patients (2016) Hum Heredity, 80 (3), pp. 139-143
• Parera, V.E., Koole, R., Alcira, B., De Rooij Felix, Coproporphyria in Argentinean Patients: Genetic Studies [resumen] (2003) Physiol Res, 52, p. 19
• Medina, N.M., Colombo, F.P., Melito, V.A., Batlle, A., Rossetti, M.V., Parera, V.E., Coproporfiria hereditaria: dos nuevas mutaciones en el gen de la coproporfirinógeno oxidasa [resumen] (2013) Medicina, 73, p. 280
• Siegesmund, M., Van Tuyll Van Serooskerken, A.M., Poblete-Gutiérrez, P., Frank, J., The acute hepatic porphyrias: Current status and future challenges (2010) Best Pract Res Clin Gastroenterol, 24 (5), pp. 593-605
• Anderson, K.E., Kappas, A., The porphyries (2010) Metabolism, 33 (4). , En: BC Decker inc (ed)
• Granata, B.X., Parera, V.E., Melito, V.A., Teijo, M.J., Batlle, A.M., Rossetti, M.V., The very first description of a patient with hepatoerythropoietic porphyria in Argentina. Biochemical and molecular studies (2009) Cell Mol Biol (Noisy-le-grand), 55 (1), pp. 61-65
• Méndez, M., Sorkin, L., Rossetti, M.V., Astrin, K.H., Batlle, A., Parera, V.E., Familial Porphyria Cutanea Tarda: Characterization of seven novel Uroporphyrinogen Decarboxylase gene mutations and frequency of common Hemochromatosis alleles (1998) Am J Hum Genet, 63, pp. 1365-1375
• Méndez, M., Rossetti, M.V., De Siervi, A., Batlle, A., Parera, V.E., Mutations in Familial Porphyria Cutanea Tarda: Two novel and two previously described for Hepatoerythropoietic Porphyria (2000) Hum Mut Mutation in Brief, 16 (3), pp. 269-270
• Méndez, M., Rossetti, M.V., Batlle, A., Parera, V.E., The role of inherited and acquired factors in the development of Porphyria Cutanea Tarda in the Argentinean population (2005) J Am Acad Dermatol, 52 (3), pp. 417-424
• Méndez, M., Rossetti, M.V., Gómez-Abecia, S., Morán-Jiménez, M.J., Parera, V.E., Batlle, A., Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: Characterization of four novel mutations (2012) Mol Genet Metabol, 105 (4), pp. 629-633
• Medina, N.M., Colombo, F.P., Piñeiro Pauwels, M.B., Rossetti, M.V., Batlle, A., Parera, V.E., Detección de 4 nuevas mutaciones en el gen UROD en familias con Porfiria Cutánea Tardía [resumen] (2012) Medicina, 72, p. 234
• Medina, N.M., Colombo, F.P., Rossetti, M.V., Batlle, A., Parera, V.E., Four novel UROD mutations identified in Argentinean patients with familial Porphyria Cutanea Tarda [resumen] (2013) Clin Chem Lab Med, 51 (5), pp. eA1-eA64
• Medina, N.M., Granata, B.X., Cerbino, G.N., Colombo, F.P., Rossetti, M.V., Batlle, A., Gen UROD: Estudio molecular y diagnóstico diferencial de Porfiria [resumen] (2013) J Basic Appl Gen, 24 (1), p. 136
• Colombo, F.P., Rossetti, M.V., Mendez, M., Martínez, J.E., De Salamanca Enríquez, R., Batlle, A., Functional associations of genetic variants involved in the clinical manifestation of erythropoietic protoporphyria in the Argentinean Population (2012) J Eur Dermatol Vennereol
• Gouya, L., Martin-Schmitt, C., Robreau, A.M., Austerlitz, F., Da Silva, V., Brun, P., Contribution of a common single nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria (2006) Am J Hum Genet, 78, pp. 2-14
• Gouya, L., Puy, H., Lamoril, J., Da Silva, V., Grandchamp, B., Nordmann, Y., Inheritance in erythropoietic protoporphyria: A common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation (1999) Blood, 93 (6), pp. 2105-2110
• Gouya, L., Puy, H., Robreau, A.M., Bourgeois, M., Lamoril, J., Da Silva, V., The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH (2002) Nat Genet, 30 (1), pp. 27-28
• Whatley, S.D., Ducamp, S., Gouya, L., Grandchamp, B., Beaumont, C., Badminton, M.N., C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload (2008) Am J Hum Genet, 83 (3), pp. 408-414
• Parera, V.E., Koole, R.H., Minderman, G., Rossetti, M.V., Batlle, A., De Rooij, F., Novel null-allele mutations and genotype-phenotype correlation in Argentinean patients with Erythropoietic Protoporphyria (2009) Mol Med, 15, pp. 425-431
• Deybach, J.C., De Verneuil, H., Phung, N., Nordmann, Y., Puissant, A., Boffety, B.J., Congenital erythropoietic porphyria (Günther's disease): Enzymatic studies in two cases of late onset (1981) Lab Clin Med, 97 (4), pp. 551-558
• Piñeiro Pauwels, M.B., Gerez, E.N., Melito, V.A., Martínez, M., Batlle, A., Parera, V., Transplante de médula ósea como tratamiento en la Porfiria Congénita Eritropoyética. Evolución del cuadro bioquímico y genético [resumen] (2009) Medicina, 69, p. 101
• Schüller, A., Salamanca, R., (2000) Metabolismo de Las Porfirinas y Porfirias, , Madrid: Ed. Complutense
• Albers, J.W., Fink, J.K., Porphyric neuropathy (2004) Muscle Nerve, 30 (4), pp. 410-422
• Pischik, E., Kauppinen, R., Neurological manifestations of acute intermittent porphyria (2009) Cell Mol Biol (Noisy-le-grand), 55 (1), pp. 72-83
• Besur, S., Hou, W., Schmeltzer, P., Bonkovsky, H., Clinically Important features of porphyrin and heme metabolism and the porphyrias (2014) Metabolites, 4 (4), pp. 977-1006
• Herrick, A.L., McColl, K.E.L., Acute intermittent porphyria (2006) Best Practice Res. Clin Gastroenterol, 19, pp. 135-249
• Princ, F., Juknat, A., Batlle, A., Porphyrinogenesis in rat cerebellum. Effect of high delta-aminolevulinic acid concentration (1994) Gen Pharmacol, 25, pp. 761-766
• Stummer, W., Stocker, S., Novotny, A., Heimann, A., Sauer, O., Kempski, O., In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid (2008) J Photochem Photobiol, 45, pp. 160-169
• Bechara, E., Oxidative stress in acute intermittent porphyria and lead poisoning may be triggered by 5-aminolevulinic acid (1996) Braz J Med Biol Res, 29, pp. 841-851
• Demasi, M., Penalti, C., DeLucia, R., Bechara, E., The prooxidant effect of 5-aminolevulinic acid in the brain tissue of rats: Implications in neuropsychiatric manifestations in porphyrias (1996) Free Rad Biol Med, 20, pp. 291-299
• Ennis, S., Novotny, A., Xiang, J., Shakui, P., Masada, T., Stummer, W., Transport of 5-aminolevulinic acid between blood and brain (2003) Brain Res, 959, pp. 226-234
• Adhikari, A., Penatti, C., Resende, R., Ulrico, H., Britto, L., Bechara, E., 5- aminolevulinate and 4,5-dioxovalerate ions decrease GABA(A) receptor density in neuronal cells, synaptosomes and rat brain (2006) Brain Res, 1093, pp. 95-104
• Emanuelli, T., Pagel, F., Porciuncula, L., Souza, D., Effects of 5-aminolevulinic acid on the glutamatergic neurotransmission (2003) Neurochem Int, 42, pp. 115-121
• Lavandera, J., Rodríguez, J., Ruspini, S., Martínez, M., Del, C., Gerez, E., Batlle, A., Pleiotropic effects of 5-aminolevulinic acid in mice brain (2016) Biochem.Cell Biol, 94, pp. 1-9. , http://dx.doi.org/10.1139/bcb-2015-0094
• Quail, A., Modern inhalation anaesthetic agents. A review of halothane, isoflurane and enflurane (1989) Med J Austr, 150, pp. 95-102
• Behne, M., Wilke, H.J., Harder, S., Clinical pharmacokinetics of sevoflurane (1999) Clin Pharmacokinet, 36, pp. 13-26
• Kharasch, E., Thummel, K., Identification of cytochrome P-450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane and methoxyflurane (1993) Anesthesiology, 79, pp. 795-807
• Buzaleh, A.M., De Salamanca Enríquez, R., Batlle, A.M., Porphyrinogenic properties of the anesthetic enflurane (1992) Gen Pharmac, 23, pp. 665-669
• Buzaleh, A.M., De Salamanca Enríquez, R., Batlle, A.M., Administration of the anesthetic isoflurane to mice: A model for acute intermittent porphyria? (1992) J Pharmacol Toxicol Methods, 28 (4), pp. 191-197
• Buzaleh, A.M., De Salamanca Enríquez, R., Batlle, A., Effect of multiple doses of volatile anesthetics on heme enzymes (1994) Gen Pharmac, 25, pp. 1179-1183
• Buzaleh, A.M., Vazquez, E., Nuñez, G., Batlle, A., Effect of chronic anesthesia on the drug metabolizing enzyme system and heme pathway regulation (1997) Gen Pharmac, 28, pp. 577-582
• Sampayo, R., Lavandera, J., Batlle, A., Buzaleh, A.M., Sevoflurane: Its action on heme metabolism and Phase i drug metabolizing system (2009) Cell Mol Biol (Noisy-le-grand), 55 (2), pp. 134-140
• Buzaleh, A.M., Batlle, A., Strain and sex differences in the effect of enflurane and isoflurane on heme metabolism in mice (1996) Gen Pharmac, 27, pp. 1009-1012
• Buzaleh, A.M., Vazquez, E., Batlle, A., Alterations in fluorinated ether anesthetics effects on heme metabolism following chronic ethanol consumption (1995) Gen Pharmac, 26, pp. 1425-1429
• Buzaleh, A.M., Martínez, M., Del, C., Batlle, A., Relevance of cytochrome P450 levels in the actions of enflurane and isoflurane in mice (2000) Studies on the Haem Pathway. Clin Exp Pharmacol Physiol, 27, pp. 796-800
• Buzaleh, A.M., Batlle, A., Glutathione depletion and anaesthesia in mice alter heme and drug metabolising enzymes (2005) Biochim Biophys Acta, 1723, pp. 128-134
• Buzaleh, A.M., Batlle, A., Administration of volatile anaesthetics to animals treated with cobalt as inductor of heme oxygenase (2000) Pharmacology Rev Communications, 11, pp. 39-47
• Lindberg, R.L., Porcher, C., Grandchamp, B., Ledermann, B., Bürki, K., Brandner, S., Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria (1996) Nat Genet, 12 (2), pp. 195-199
• Ruspini, S., Zuccoli, J., Lavandera, J., Batlle, A., Buzaleh, A.M., Efecto de los anestésicos Isoflurano y Sevoflurano sobre la biosíntesis del hemo en un modelo murino de Porfiria Aguda Intermitente [resumen] (2012) Medicina, 72, p. 121
• Buzaleh, A.M., García Bravo, M., Navarro, S., Moran Jimenez, M.J., Méndez, M., Batlle, A., Volatile anaesthetics induce biochemical alterations in the heme pathway in a B-lympocyte cell line established from hepatoerythropoietic porphyria patients (LBHEP) and in mice inoculated with LBHEP cells (2004) Int J Biochem Cell Biol, 36, pp. 216-222
• Buzaleh, A.M., Morán-Jiménez, M.J., García-Bravo, M., Sampedro, A., Batlle, A., De Salamanca Enríquez, R., Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria (2009) Cell Mol Biol (Noisy-le-grand), 55 (1), pp. 38-44
• Buzaleh, A.M., Moreno-Carralero, M.I., Méndez, M., Batlle, A., De Salamanca Enríquez, R., Morán-Jimenez, M.J., Heme metabolism, oxidative and nitrosative markers in a mouse model of hemochromatosis. Effect of isoflurane, ethanol and 5-aminolevulinic acid (2013) J Pathol Res, 2, pp. 15-20
• Rodríguez, J.A., Buzaleh, A.M., Fossati, M., Azcurra, J., Batlle, A.M., Del, C., The effects of some porphyrinogenic drugs on the brain cholinergic system (2002) Cell Mol Biol (Noisy-le-grand), 48 (1), pp. 103-110
• Lavandera, J., Fossatti, M., Azcurra, J., Batlle, A., Buzaleh, A.M., Glutamatergic system: Another target for the action of porphyrinogenic agents (2009) Cell Mol Biol (Noisy-le-grand), 55 (1), pp. 23-28
• Rodriguez, J.A., Martinez Del, M.C., Gerez, E., Batlle, A., Buzaleh, A.M., Heme oxygenase, aminolevulinate acid synthetase and the antioxidant system in the brain of mice treated with porphyrinogenic drugs (2005) Cell Mol Biol (Noisy-le-grand), 51, pp. 487-494
• Lavandera, J., Batlle, A., Buzaleh, A.M., Metabolization of porphyrinogenic agents in brain: Involvement of the Phase i drug metabolizing system. A comparative study in liver and kidney (2007) Cell Mol Neurobiol, 27, pp. 717-729
• Lavandera, J., Ruspini, S., Batlle, A., Buzaleh, A.M., Cytochrome P450 expression in mouse brain: Specific isoenzymes involved in phase i metabolizing system of porphyrinogenic agents in both microsomes and mitochondria (2014) Biochem Cell Biol, 92, pp. 1-6. , http://dx.doi.org/10.1139/bcb-2014-0088
• Lavandera, J., Batlle, A., Buzaleh, A.M., Mice brain nitric oxide synthase response induced by anaesthetics and other porphyrinogenic drugs (2011) Drug Metab Lett, 5, pp. 25-29
• Buzaleh, A.M., Meiss, R., Lavandera, J., Vallecorsa, P., Ruspini, S., Batlle, A., Óxido nítrico sintasa y hemo oxigenasa en encéfalo de ratones tratados con anestésicos volátiles y otros agentes porfirinogénicos. Estudio inmunohistoquímico de la expresión proteica [resumen] (2012) Medicina, 72, p. 121
• Zuccoli, J., Ruspini, S., Batlle, A., Buzaleh, A.M., Alteración en las actividades enzimáticas de los complejos de la cadena respiratoria mitocondrial (I-III II-III y IV) por efecto de agentes porfirinogénicos [resumen] (2013) Medicina, 73, p. 256
• Batlle, A., Llambías, E.B.C., De Xifra Wider, E.A., Tigier, H.A., Porphyrin biosynthesis in soybean callus system XV. The effect of growth conditions (1975) Int J Biochem, 6, pp. 591-606
• Fukuda, H., Casas, A., Batlle, A., Aminolevulinic acid: From its unique biological function to its star role in photodynamic therapy (2005) Int J Biochem Cell Biol, 37, pp. 272-276
• Fukuda, H., Casas, A., Batlle, A., Use of ALA and ALA derivatives for optimizing ALA-PDT. A Review of our experience (2006) J Envir Pathol Toxicol Oncol, 25, pp. 127-143
• Fukuda, H., Paredes, S.R., Batlle, A.M., Del, C., Tumor localizing properties of porphyrins. in vivo studies using free and liposome encapsulated aminolevulinic acid (1992) Comp Biochem Physiol, 102 B, pp. 433-436
• Alvarez, M.G., Lacelli, M.S., Rivarola, V., Batlle, A., Fukuda, H., 5-aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells (2007) J Env Pathol Toxicol Oncol, 26 (2), pp. 75-82
• Alvarez, M.G., Milanesio, M., Rivarola, V., Durantini, E., Batlle, A., Fukuda, H., Endogenous and exogenous porphyrins as photosensitizers in the HEP-2 human carcinoma line (2009) Cell Mol Biol (Noisy-le-grand), 55 (2), pp. 8-14
• Hrkal, Z., Grebenová, D., Cajthamlová, H., Soucek, J., Bartosová, J., Fuchs, O., Use of photodynamic therapy for elimination of residual leukemic cells in autologous transplants of hematopoietic progenitor cells (2002) Cas Lek Cesk, 141, pp. 41-46
• Huang, H.F., Chen, Y.Z., Wu, Y., Chen, P., Purging of murine erythroblastic leukemia by ZnPcS2P2-based-photodynamic therapy (2006) Bone Marrow Transplant, 37 (2), pp. 213-217
• Capella, M.A., Capella, L.S., A light in multidrug resistance: Photodynamic treatment of multidrug-resistant tumors (2003) J Biomed Sci, 10 (4), pp. 361-366
• Chu, E.S., Yow, C.M., Shi, M., Ho, R.J., Effects of photoactivated 5-aminolevulinic acid hexyl ester on MDR1 over-expressing human uterine sarcoma cells (2008) Toxicol Lett, 181 (1), pp. 7-12
• Tang, P.M., Zhang, D.M., Xuan, N.H., Tsui, S.K., Waye, M.M., Kong, S.K., Photodynamic therapy inhibits P-glycoprotein mediated multidrug resistance via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a (2009) Mol Cancer, 8, p. 56
• Diez, B., Cordo Russo, R., Teijo, M.J., Hajos, S., Batlle, A., Fukuda, H., ROS production by endogenously generated Protoporphyrin IX in murine leukemia cells (2009) Cell Mol Biol (Noisy-le-grand), 55 (2), pp. 15-19
• Diez, B., Ernst, G., Teijo, M.J., Batlle, A., Hajos, S., Fukuda, H., Combined chemotherapy and ALA based Photodynamic Therapy in leukemic murine cells (2012) Leukemia Res, 36, pp. 1179-1184
• Canti, B., Nicolin, A., Cubeddu, R., Taroni, P., Bandieramonte, G., Valentini, G., Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors (1998) Cancer Lett, 125, pp. 39-44
• Snyder, J.W., Greco, W.R., Bellnier, D.A., Vaughan, L., Henderson, B.W., Photodynamic therapy: A means to enhanced drug delivery to tumors (2003) Cancer Res, 63 (23), pp. 8126-8131
• Kirveliene, V., Grazeliene, G., Dabkeviciene, D., Micke, I., Kirvelis, D., Juodka, B., Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo (2006) Cancer Chemother Pharmacol, 57 (1), pp. 65-72
• Anand, S., Honari, G., Hassan, T., Elson, P., Maytin, E.V., Low-dose methotrexate enhances aminolevulinate-based photodynamic therapy in skin carcinoma cells in vitro and in vivo (2009) Clin Cancer Res, 15 (10), pp. 3333-3343
• Xie, Q., Jia, L., Liu, Y.H., Wei, C.G., Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo (2009) World J Gastroenterol, 15 (6), pp. 737-741
• Diez, B., Hajos, S., Meiss, R., Ernst, G., Teijo, M.J., Batlle, A., (2015) Vitro and in Vivo 5-Aminolevulinic Acid-Based Photodynamic Therapy in Sensitive and Drug Resistant Leukemic Murine Cells, pp. 173-191. , En: Photodynamic Therapy: Fundamentals, Applications and Health Outcome Effects. Ed Adrian Hugo, Hauppauge, NY, Cap 7
• Canti, G., Calastretti, A., Bevilacqua, A., Reddi, E., Palumbo, G., Nicolin, A., Combination of photodynamic therapy + immunotherapy + chemotherapy in murine leukemia (2010) Neoplasma, 57 (2), pp. 184-188
• Cassinelli, J., Teijo, M.J., Rossetti, M.V., Fukuda, H., Batlle, A., Porphyrin biosynthesis and photosensitization in human and murine lung adenocarcinoma cell lines (2013) Clin Chem Lab Med, 51 (5), p. P51. , eA51
• Teijo, M.J., Meiss, R., Diez, B., Batlle, A., Fukuda, H., Reactive Oxygen Species as main factors conditioning cell death in response to ALA-based Photodynamic Therapy in human lung adenocarcinoma spheroids (2012) J Thor Oncol, 7 (7), pp. S101-S156
• Fukuda, H., Teijo, M.J., Batlle, A., Human lung adenocarcinoma cells sensitive and resistant to ALA-based Photodynamic Therapy [resumen] (2014) J Thor Oncol, 9 (9), p. S175
• Teijo, M.J., Diez, B., Batlle, A., Fukuda, H., Modulation of 5-Aminolevulinic acid mediated photodynamic therapy induced cell death in a human lung adenocarcinoma cell line (2016) ICST
• Salzman, T.A., Stella, A.M., De Xifra Wider, E.A., Batlle, A.M., Del, C., Docampo, R., Stoppani, A.O.M., Porphyrin biosynthesis in parasitic hemoflagellates: Functional and defective enzymes in Trypanosoma cruzi (1982) Comp Biochem Physiol, 72 B, pp. 663-667
• Salzman, T.A., Batlle, A.M., Del, C., De Souza, W., Heme synthesis in Trypanosoma cruzi: Influence of the strain and culture medium (1986) Comp Biochem Physiol, 83 B, pp. 57-61
• Lombardo, M.E., Araujo, L.S., Batlle, A., 5-Aminolevulinic acid synthesis in epimastigotes of Trypanosoma cruzi (2003) Int J Biochem Cell Biol, 35, pp. 1263-1271
• Beale, S.I., Castelfranco, P.A., The biosynthesis of δ-aminolevulinic acid in higher plants. II. Formation of 14C-δ-aminolevulinic acid from labeled precursors in greening plant tissues (1974) Plant Physiol, 53, pp. 297-303
• Salvador, G.F., La Synthese d'acide δ-aminolevulinique par des chloroplastes isoles d'Euglena gracilis (1978) C R Acad Sci Paris, 286, pp. 49-52
• Lombardo, M.E., Araujo, L.S., Juknat, A.A., Batlle, A.M., Del, C., Effect of illumination on growth, chlorophyll content and delta-aminolevulinic acid synthesis in Euglena gracilis (1988) Comp Biochem Physiol, 91 B, pp. 279-284
• Lombardo, M.E., Araujo, L.S., Juknat, A.A., Batlle, A.M., Del, C., Glutamate 4,5-dioxovaleric acid transaminase from Euglena gracilis. Kinetic studies (1989) Eur J Biochem, (182), pp. 657-660
• Lombardo, M.E., Araujo, L.S., Batlle, A.M., Del, C., Kinetic studies on the glutamate: Glyoxylate transaminase of Euglena gracilis (1996) J Photochem Photobiol, 36, pp. 241-244
• Salzman, T.A., Batlle, A.M., Del, C., Heme synthetase in Trypanosoma cruzi (1986) Comp Biochem Physiol, 85 B, pp. 537-541
• Ciccarelli, A., Araujo, L., Batlle, A., Lombardo, E., Effect of haemin on growth, protein content and the antioxidant defence system in Trypanosoma cruzi (2007) Parasitology, 134, pp. 959-965
• Chen, J., London, I., Regulation of protein synthesis by heme-regulated eIF-2α kinase (1995) Trends Biochem Sci, 20, pp. 105-108
• Pal, J., Joshi-Purandare, M., Dose-dependent differential effect of hemin on protein synthesis and cell proliferation in Leishmania donovani promastigotes cultured in vitro (2001) J Biosci, 26, pp. 225-231
• Kumar, S., Bandyopadhyay, U., Free heme toxicity and its detoxification systems in human (2005) Toxicol Lett, 157, pp. 175-188
• Turrens, J.F., Oxidative stress and antioxidant defenses: A target for the treatment of diseases caused by parasitic protozoa (2004) Mol Aspects Med, 25, pp. 211-220
• Motterlini, R., Green, C., Foresti, R., Regulation of heme oxygenase-1 by redox signals involving nitric oxide (2002) Antioxid Redox Signal, 4, pp. 615-624
• Ciccarelli, A., Frank, F., Puente, V., Malchiodi, E., Batlle, A., Lombardo, M.E., Anti-parasitic effect of vitamin B12 on Trypanosoma cruzi (2012) Antimicrob Agents Chemother, 56, pp. 5315-5320
• Solovieva, M.E., Soloviev, V.V., Akatov, V.S., Vitamin B12b increases the cytotoxicity of short-time exposure to ascorbic acid, inducing oxidative burst and iron-dependent DNA damage (2007) Eur J Pharmacol, 566, pp. 206-214
• Solovieva, M.E., Soloviev, V.V., Kudryavtsev, A.A., Trizna, Y.A., Akatov, V.S., Vitamin B12b enhances the cytotoxicity of dithiothreitol (2008) Free Radic Biol Med, 44, pp. 1846-1856
• Kauppinen, R., Mustajoki, S., Pihlaja, H., Peltonen, L., Mustajoki, P., Acute intermittent porphyria in Finland: 19 mutations in the porphobilinogen deaminase gene (1995) Hum Mol Genet, 4 (2), pp. 215-222
• Lundin, G., Hashemi, J., Floderus, Y., Thunell, S., Sagen, E., Laegreid, A., Four mutations in the porphobilinogen deaminase gene in patients with acute intermittent porphyria (1995) J Med Genet, 32 (12), pp. 979-981
• Gregor, A., Schneider-Yin, X., Szlendak, U., Wettstein, A., Lipniacka, A., Rüfenacht, U.B., Molecular study of the hydroxymethylbilane synthase gene (HMBS) among Polish patients with acute intermittent porphyria (2002) Hum Mut, 19 (3), p. 310
• Luchinina, Y.A., Surin, V.L., Luk'Yanenko, A.V., Karpova, I.V., Pustovoit, Y.S., Kravchenko, S.K., Molecular diagnostics of acute intermittent porphyria in Russia [Resumen] (1995) Eur J Hum Genet, 13, p. 134
• Hessels, J., Voortman, G., Van Der Wagen, A., Van Der Elzen, C., Scheffer, H., Zuijderhoudt, F.M., Homozygous acute intermittent porphyria in a 7-years-old boy with massive excretions of porphyrins and porphyrin precursors (2004) J Inherit Metab Dis, 27, pp. 19-27
• Gu, X.F., De Rooij, F., De Baar, E., Bruyland, M., Lissens, W., Nordmann, Y., Two novel mutations of the porphobilinogen deaminase gene in acute intermittent porphyria (1993) Hum Mol Genet, 2 (10), pp. 1735-1736
• Cappellini, M.D., Di Montemuros Martinez, F., Di Pierro, E., Fiorelli, G., Hematologically important mutations: Acute intermittent porphyria (2002) Blood Cells Mol Dis, 28 (1), pp. 5-12
• Gerez, E., Cerbino, G., Colombo, F., Parera, V., Batlle, A., Rossetti, M.V., A novel splicing mutation (C.450-2A>G) in an Argentinean family with Acute Intermittent Porphyria (2011) GENE BANK, p. HM856802
• Delfau, M.H., Picat, C., De Rooij, F., Voortman, G., Deybach, J.C., Nordmann, Y., Molecular heterogeneity of acute intermittent porphyria: Identification of four additional mutations resulting in the CRIM-negative subtype of the disease (1991) Am J Hum Genet, 49 (2), pp. 421-428
• Delfau, M.H., Picat, C., De Rooij, F.W., Hamer, K., Bogard, M., Wilson, J.H., Two different point G to A mutations in exon 10 of the porphobilinogen deaminase gene are responsible for acute intermittent porphyria (1990) J Clin Invest, 86 (5), pp. 1511-1516
• Kauppinen, R., Peltonen, L., Pihlaja, H., Mustajoki, P., CRIM-positive mutations of acute intermittent porphyria in Finland (1992) Hum Mutat, 1 (5), pp. 392-396
• Lundin, G., Wedell, A., Thunell, S., Anvret, M., Two new mutations in the porphobilinogen deaminase gene and a screening method using PCR amplification of specific alleles (1994) Hum Genet, 93 (1), pp. 59-62
• Mgone, C.S., Lanyon, W.G., Moore, M.R., Louie, G.V., Connor, J.M., Identification of five novel mutations in the porphobilinogen deaminase gene (1994) Hum Mol Genet, 3 (5), pp. 809-811
• Mgone, C.S., Lanyon, W.G., Moore, M.R., Louie, G.V., Connor, J.M., Detection of a high mutation frequency in exon 12 of the porphobilinogen deaminase gene in patients with acute intermittent porphyria (1993) Hum Genet, 92 (6), pp. 619-622
• Puy, H., Deybach, J.C., Lamoril, J., Robreau, A.M., Nordmann. Detection of four novel mutations in the porphobilinogen deaminase gene in French Caucasian patients. with acute intermittent porphyria (1996) Hum Hered, 46 (3), pp. 177-180
• Puy, H., Deybach, J.C., Lamoril, J., Robreau, A.M., Silva, V.D., Gouya, L., Molecular epidemiology and diagnosis of PBGD gene defects in AIP (1997) Am J Hum Genet, 60, pp. 1373-1383
• Floderus, Y., Shoolingin-Jordan, P.M., Harper, P., Acute intermittent porphyria in Sweden. Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene (2002) Clin Genet, 62 (4), pp. 288-297
• Schuurmans, M.M., Schneider-Yin, X., Rüfenacht, U.B., Schnyder, C., Minder, C.E., Puy, H., Influence of age and gender on the clinical expression of acute intermittent porphyria based on molecular study of porphobilinogen deaminase gene among Swiss patients (2001) Mol Med, 7 (8), pp. 535-542
• Wiman, A., Harper, P., Floderus, Y., Nine novel mutations in the protoporphyrinogen oxidase gene in Swedish families with variegate porphyria (2003) Clin Genet, 64 (2), pp. 122-130
• Granata, B.X., (2013) Porfirias Hepáticas Agudas. Relación Con El Estrés Oxidativo y Patologías Asociadas (Tesis de Doctorado), UBA
• Whatley, S.D., Puy, H., Morgan, R.R., Robreau, A.M., Roberts, A.G., Nordmann, Y., Variegate porphyria in Western Europe: Identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation (1999) Am J Hum Genet, 65 (4), pp. 984-994
• Deybach, J.C., Puy, H., Robréau, A.M., Lamoril, J., Da Silva, V., Grandchamp, B., Mutations in the protoporphyrinogen oxidase gene in patients with variegate porphyria (1996) Hum Mol Genet, 5 (3), pp. 407-410
• Frank, J., Jugert, F.K., Merk, H.F., Kalka, K., Goerz, G., Anderson, K., A spectrum of novel mutations in the protoporphyrinogen oxidase gene in 13 families with variegate porphyria (2001) J Invest Dermatol, 116 (5), pp. 821-823
• Cerbino, G., Rossetti, M.V., Batlle, A., Parera, V.E., Porfiria Cutánea Tardía. Diagnóstico molecular en pacientes argentinos [resumen] (2014) J Basic Appl Genetics, 25, p. 111
• McManus, J.F., Begley, C.G., Sassa, S., Ratnaike, S., Five new mutations in the uroporphyrinogen decarboxylase gene identified in families with cutaneous porphyria (1996) Blood, 88 (9), pp. 3589-3600
• Morán Jiménez, M.J., Ged, C., Romana, M., De Salamanca Enríquez, R., Taïeb, A., Topi, G., Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria (1996) Am J Hum Genet, 58, pp. 712-721
• Badenas, C., To-Figueras, J., Phillips, J.D., Warby, C.A., Muñoz, C., Herrero, C., Identification and characterization of novel uroporphyrinogen decarboxylase gene mutations in a large series of porphyria cutanea tarda patients and relatives (2009) Clin Genet, 75 (4), pp. 346-353
• Meguro, K., Fujita, H., Ishida, N., Akagi, R., Kurihara, T., Galbraith, R.A., Molecular defects of uroporphyrinogen decarboxylase in a patient with mild hepatoerythropoietic porphyria (1994) J Invest Dermatol, 102 (5), pp. 681-685
• Brancaleoni, V., Di Pierro, E., Besana, V., Ausenda, S., Cappellini, M.D., Novel human pathological mutations. Gene symbol: UROD. Disease: Porphyria, cutaneous (2007) Hum Genet, 122 (5), pp. 554-555
• Brady, J.J., Jackson, H.A., Roberts, A.G., Morgan, R.R., Whatley, S.D., Rowlands, G.L., Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda (2000) J Invest Dermatol, 115 (5), pp. 868-874
• Wang, X., Piomelli, S., Peacocke, M., Christiano, A.M., Poh-Fitzpatrick, M.B., Erythropoietic protoporphyria: four novel frameshift mutations in the ferrochelatase gene (1997) J Invest Dermatol, 109 (5), pp. 688-691
• Henriksson, M., Timonen, K., Mustajoki, P., Pihlaja, H., Tenhunen, R., Peltonen, L., Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients (1996) J Invest Dermatol, 106, pp. 346-350
• Schneider-Yin, X., Schäfer, B.W., Tönz, O., Minder, E.I., Human ferrochelatase: A novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing (1995) Hum Genet, 95 (4), pp. 391-396
• Frank, J., Nelson, J., Wang, X., Yang, L., Ahmad, W., Lam, H., Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies (1999) J Investig Med, 47, pp. 278-284
• Imoto, S., Tanizawa, Y., Sato, Y., Kaku, K., Oka, Y., A novel mutation in the ferrochelatase gene associated with erytropoietic protoporphyria (1996) Br J Haematol, 94, pp. 191-197
• Di Pierro, E., Moriondo, V., Cappellini, M.D., Gene symbol: FECH. Disease: Porphyria, erythropoietic (2004) Hum Genet, 114 (6), p. 609
• Melito, V., Colombo, F., Granata, B.X., Cano, G., Infante, L., Batlle, A., Rossetti, M.V., Parera, V.E., Nueva variante mutacional del gen FECH asociada a un caso grave de Porfiria Cutánea atípica [resumen] (2011) Medicina, 71, p. 67
• Di Pierro, E., Brancaleoni, V., Moriondo, V., Besana, V., Cappellini, M.D., Co-existence of two functional mutations on the same allele of the human ferrochelatase gene in erythropoietic protoporphyria (2007) Clin Genet, 71, pp. 84-88
• Colombo, F.P., Martinez, J.E., Rossetti, M.V., Batlle, A., Parera, V.E., Prevalencia de mutaciones nonsense en pacientes con Protoporfiria Eritropoyética [resumen] (2009) LILLOA, 45, p. 142

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------